Human Vaccines & Immunotherapeutics, Volume 7, Issue 3 (2011)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Human Vaccines, Volume 7, Issue 3 (2011)

See all volumes and issues
Vol 20, 2024 Vol 19, 2023 Vol 18, 2022 Vol 17, 2021 Vol 16, 2020 Vol 15, 2019 Vol 14, 2018 Vol 13, 2017 Vol 12, 2016 Vol 11, 2015 Vol 10, 2014 Vol 9, 2013 Vol 8, 2012 Volume 7, 2011 Vol 6, 2010 Vol 5, 2009 Vol 4, 2008 Vol 3, 2007 Vol 2, 2006 Vol 1, 2005
Download citations Download PDFs Download issue

Editor's Corner

Editorial
Letter from the Editor
Ronald W. Ellis & Eva M. Riedmann
Page: 285
Published online: 01 Mar 2011
CitationforLetter from the Editor | PDF (221.7 KB)
  • 47 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

News, Policy & Profiles

News
News
Eva M. Riedmann
Pages: 286-289
Published online: 01 Mar 2011
AbstractforNews | PDF (264.4 KB)
  • 141 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
News
High time for GAVI to push for lower prices
Daniel Berman & Rohit Malpani
Page: 290
Published online: 01 Mar 2011
AbstractforHigh time for GAVI to push for lower prices | PDF (225.3 KB)
  • 162 Views
  • 12 CrossRef citations
  • 0Altmetric
Open Access
News
Beyond patents: The GAVI Alliance, AMCs and improving immunization coverage through public sector vaccine production in the global south
Anne-Emanuelle Birn & Joel Lexchin
Pages: 291-292
Published online: 01 Mar 2011
AbstractforBeyond patents: The GAVI Alliance, AMCs and improving immunization coverage through public sector vaccine production in the global south | PDF (255.2 KB)
  • 644 Views
  • 11 CrossRef citations
  • 0Altmetric
Open Access
News
The pilot AMC: The acceptance of policy evolution
Jim Dobbins, Lord Avebury & Hugh McKinney
Page: 293
Published online: 01 Mar 2011
AbstractforThe pilot AMC: The acceptance of policy evolution | PDF (229.5 KB)
  • 149 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access
News
Diverse tools needed to ensure affordable vaccines for the poor
Christopher J. Elias
Page: 294
Published online: 01 Mar 2011
AbstractforDiverse tools needed to ensure affordable vaccines for the poor | PDF (222.7 KB)
  • 204 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access
News
Fixing GAVI’s cash crunch
Andrew Farlow
Pages: 295-296
Published online: 01 Mar 2011
AbstractforFixing GAVI’s cash crunch | PDF (258.6 KB)
  • 148 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access
News
Getting priorities straight
Richard T. Mahoney
Page: 297
Published online: 01 Mar 2011
AbstractforGetting priorities straight | PDF (224.2 KB)
  • 92 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access
News
New vaccines for the least developed countries
Mark Kane
Pages: 298-299
Published online: 01 Mar 2011
AbstractforNew vaccines for the least developed countries | PDF (235 KB)
  • 174 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access
News
The AMC is helping save children’s lives today
Nina Schwalbe
Pages: 300-301
Published online: 01 Mar 2011
AbstractforThe AMC is helping save children’s lives today | PDF (236.9 KB)
  • 132 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access
News
Why the AMC matters
Frederick Were
Page: 302
Published online: 01 Mar 2011
AbstractforWhy the AMC matters | PDF (220.8 KB)
  • 168 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access

Editor's Corner

Editorial
Plant biotechnology for production of recombinant pharmaceuticals
Maxim Golovkin
Pages: 303-304
Published online: 01 Mar 2011
CitationforPlant biotechnology for production of recombinant pharmaceuticals | PDF (238.5 KB)
  • 277 Views
  • 2 CrossRef citations
  • 0Altmetric
Open Access

Review

Review Article
Tobacco derived cancer vaccines for non-Hodgkin’s lymphoma: Perspectives and progress
Alison A. McCormick
Pages: 305-312
Published online: 01 Mar 2011
AbstractforTobacco derived cancer vaccines for non-Hodgkin’s lymphoma: Perspectives and progress | PDF (845.5 KB)
  • 877 Views
  • 17 CrossRef citations
  • 0Altmetric
Free Access
Review Article
Clinical development of plant-produced recombinant pharmaceuticals: Vaccines, antibodies and beyond
Vidadi Yusibov, Stephen J. Streatfield & Natasha Kushnir
Pages: 313-321
Published online: 01 Mar 2011
AbstractforClinical development of plant-produced recombinant pharmaceuticals: Vaccines, antibodies and beyond | PDF (364.7 KB)
  • 4497 Views
  • 184 CrossRef citations
  • 0Altmetric
Free Access
Review Article
Safety of plant-made pharmaceuticals: Product development and regulatory considerations based on case studies of two autologous human cancer vaccines
Daniel Tusé
Pages: 322-330
Published online: 01 Mar 2011
AbstractforSafety of plant-made pharmaceuticals: Product development and regulatory considerations based on case studies of two autologous human cancer vaccines | PDF (356.2 KB)
  • 514 Views
  • 17 CrossRef citations
  • 0Altmetric
Free Access
Review Article
Geminiviral vectors based on bean yellow dwarf virus for production of vaccine antigens and monoclonal antibodies in plants
Qiang Chen, Junyun He, Waranyoo Phoolcharoen & Hugh S. Mason
Pages: 331-338
Published online: 01 Mar 2011
AbstractforGeminiviral vectors based on bean yellow dwarf virus for production of vaccine antigens and monoclonal antibodies in plants | Full Text | References | PDF (1.6 MB)
  • 3671 Views
  • 110 CrossRef citations
  • 0Altmetric
Free Access
Review Article
Vaccine farming in Cape Town
Edward P. Rybicki, Anna-Lise Williamson, Ann Meyers & Inga I. Hitzeroth
Pages: 339-348
Published online: 01 Mar 2011
AbstractforVaccine farming in Cape Town | PDF (930.6 KB)
  • 361 Views
  • 10 CrossRef citations
  • 0Altmetric
Free Access
Review Article
Emerging antibody products and Nicotiana manufacturing
Kevin J. Whaley, Andrew Hiatt & Larry Zeitlin
Pages: 349-356
Published online: 01 Mar 2011
AbstractforEmerging antibody products and Nicotiana manufacturing | Full Text | References | PDF (738 KB)
  • 1321 Views
  • 59 CrossRef citations
  • 0Altmetric
Open Access
Review Article
Seed-based oral vaccines as allergen-specific immunotherapies
Pages: 357-366
Published online: 01 Mar 2011
AbstractforSeed-based oral vaccines as allergen-specific immunotherapies | PDF (1.7 MB)
  • 428 Views
  • 32 CrossRef citations
  • 0Altmetric
Free Access
Review Article
Transgenic crops for the production of recombinant vaccines and anti-microbial antibodies
Jenny Peters & Eva Stoger
Pages: 367-374
Published online: 01 Mar 2011
AbstractforTransgenic crops for the production of recombinant vaccines and anti-microbial antibodies | PDF (526.7 KB)
  • 1161 Views
  • 33 CrossRef citations
  • 0Altmetric
Free Access
Review Article
Molecular pharming
Future targets and aspirations
Mathew Paul, Craig van Dolleweerd, Pascal M.W. Drake, Rajko Reljic, Harry Thangaraj, Tommaso Barbi, Elena Stylianou, Ilaria Pepponi, Leonard Both, Verena Hehle, Luisa Madeira, Varghese Inchakalody, Sammy Ho, Thais Guerra & Julian K-C. Ma
Pages: 375-382
Published online: 01 Mar 2011
AbstractforMolecular pharming | Full Text | References | PDF (450.6 KB)
  • 2969 Views
  • 30 CrossRef citations
  • 0Altmetric
Free Access
Review Article
Recent advances of Cowpea mosaic virus-based particle technology
Nicholas P. Montague, Eva C. Thuenemann, Pooja Saxena, Keith Saunders, Paolo Lenzi & George P. Lomonossoff
Pages: 383-390
Published online: 01 Mar 2011
AbstractforRecent advances of Cowpea mosaic virus-based particle technology | PDF (5.2 MB)
  • 847 Views
  • 41 CrossRef citations
  • 0Altmetric
Free Access

Explore articles

Explore the most recently published articles

Risk and safety profile in checkpoint inhibitors on non-small-cel lung cancer: A systematic review
Sara Maria Majernikova
Review Article | Published online: 27 Jun 2024
Open Access
Characterization of neutralizing chimeric heavy-chain antibodies against tetanus toxin
Kexuan Cheng et al.
Article | Published online: 27 Jun 2024
Open Access
Knowledge, attitudes, and perceptions of influenza vaccine among pregnant women in Minhang District, Shanghai
Yan Lu et al.
Article | Published online: 27 Jun 2024
Open Access
The impact of previous SARS-CoV-2 infection on post-vaccine adverse events in individuals vaccinated with TURKOVAC or CoronaVac –inactivated COVID-19 vaccines
Mine Durusu Tanriover et al.
Product Review | Published online: 26 Jun 2024
Open Access